These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 2720929)
1. Effects of aspirin and prostaglandin E1 on in vitro thrombolysis with urokinase. Evidence for a possible role of inhibiting platelet activity in thrombolysis. Terres W; Beythien C; Kupper W; Bleifeld W Circulation; 1989 Jun; 79(6):1309-14. PubMed ID: 2720929 [TBL] [Abstract][Full Text] [Related]
2. [Thrombus age as a determinant of lysis efficacy of in vitro produced platelet-fibrin thrombi]. Beythien C; Terres W; Gutensohn K; Meinertz T Z Kardiol; 1996 Sep; 85(9):661-7. PubMed ID: 8992809 [TBL] [Abstract][Full Text] [Related]
3. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents. Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085 [TBL] [Abstract][Full Text] [Related]
5. Kinetics of urokinase-induced thrombolysis in a biphasic in vitro system. Iga Y; Stella SR; Chandler AB Haemostasis; 1985; 15(3):189-97. PubMed ID: 4029755 [TBL] [Abstract][Full Text] [Related]
6. Effects of streptokinase, urokinase, and recombinant tissue plasminogen activator on platelet aggregability and stability of platelet aggregates. Terres W; Umnus S; Mathey DG; Bleifeld W Cardiovasc Res; 1990 Jun; 24(6):471-7. PubMed ID: 2167173 [TBL] [Abstract][Full Text] [Related]
7. A bispecific antifibrin-antiplatelet urokinase conjugate (BAAUC) induces enhanced clot lysis and inhibits platelet aggregation. Ruef J; Nordt TK; Peter K; Runge MS; Kübler W; Bode C Thromb Haemost; 1999 Jul; 82(1):109-14. PubMed ID: 10456463 [TBL] [Abstract][Full Text] [Related]
8. Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis. Collet JP; Montalescot G; Lesty C; Soria J; Mishal Z; Thomas D; Soria C Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):142-8. PubMed ID: 11145946 [TBL] [Abstract][Full Text] [Related]
9. The thrombolytic effect of aspirin in animal model. Karmohapatra SK; Kahn NN; Sinha AK J Thromb Thrombolysis; 2007 Oct; 24(2):123-9. PubMed ID: 17396230 [TBL] [Abstract][Full Text] [Related]
10. The inability of low-molecular-weight dextran, aspirin, and prostaglandin E1 to inhibit monolayer platelet adhesion to polyethylene. Garrett KO; Pautler SV; Johnson PC J Lab Clin Med; 1993 Aug; 122(2):141-8. PubMed ID: 7688020 [TBL] [Abstract][Full Text] [Related]
11. Prevention of reoccluding platelet-rich thrombi in canine femoral arteries with a novel peptide antagonist of platelet glycoprotein IIb/IIIa receptors. Haskel EJ; Adams SP; Feigen LP; Saffitz JE; Gorczynski RJ; Sobel BE; Abendschein DR Circulation; 1989 Dec; 80(6):1775-82. PubMed ID: 2513145 [TBL] [Abstract][Full Text] [Related]
12. Thrombolytic and pharmacokinetic properties of chimeric tissue-type and urokinase-type plasminogen activators. Collen D; Lu HR; Lijnen HR; Nelles L; Stassen JM Circulation; 1991 Sep; 84(3):1216-34. PubMed ID: 1909220 [TBL] [Abstract][Full Text] [Related]
14. Patho-physiological studies on lactic acid-induced pulmonary thrombosis in rat. I. Effect of heparin, acetylsalicylic acid, urokinase and tranexamic acid. Tomikawa M Thromb Diath Haemorrh; 1975 Sep; 34(1):145-58. PubMed ID: 1188708 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical and histochemical investigations on in vivo thrombolysis with urokinase in rabbits. Hisano S; Sueishi K; Ishii Y; Tanaka K Thromb Haemost; 1979 Jun; 41(4):796-803. PubMed ID: 483251 [TBL] [Abstract][Full Text] [Related]
17. Effet of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3':5'-cyclic monophosphate. Ball G; Brereton GG; Fulwood M; Ireland DM; Yates P Biochem J; 1970 Dec; 120(4):709-18. PubMed ID: 4322038 [TBL] [Abstract][Full Text] [Related]
18. Studies on platelet aggregation inhibitors in vivo. X. Relationship to thrombolysis. Ambrus JL; Ambrus CM; Sharma SD; Suh OW; Gastpar H J Med; 1982; 13(5-6):365-71. PubMed ID: 6221055 [TBL] [Abstract][Full Text] [Related]
19. The features of thrombus in a microvessel injury model and the antithrombotic efficacy of heparin, urokinase, and prostaglandin E1. Hashimoto I; Nakanishi H; Shono Y; Yamano M; Toda M Plast Reconstr Surg; 2003 Jun; 111(7):2307-14. PubMed ID: 12794473 [TBL] [Abstract][Full Text] [Related]
20. Platelet-targeted fibrinolysis enhances clot lysis and inhibits platelet aggregation. Bode C; Meinhardt G; Runge MS; Freitag M; Nordt T; Arens M; Newell JB; Kübler W; Haber E Circulation; 1991 Aug; 84(2):805-13. PubMed ID: 1860223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]